FoxO1 regulates apoptosis induced by asbestos in the MT-2 human T-cell line

References

• Accili D, Arden KC. 2004. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 117:421–426.
   PubMed Web of Science ®Google Scholar
• Anraku M, Cunningham KS, Yun Z, Tsao MS, Zhang L, Keshavjee S, Johnston MR, De Perrot M. 2008. Impact of tumor-infiltrating T-cells on survival in patients with malignant pleural mesothelioma. J Thoracic Cardiovasc Surg. 135:823–829.
   PubMed Web of Science ®Google Scholar
• Bott M, Brevet M, Taylor BS, Shimizu S, Ito T, Wang L, Creaney J, Lake RA, Zakowski MF, Reva B, et al. 2011. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet. 43:668–672.
   PubMed Web of Science ®Google Scholar
• Craighead JE, Craighead J, Gibbs A, Editors. 2008. Diseases associated with asbestos industrial products and environmental exposure. New York: Oxford University Press.
   Google Scholar
• Eijkelenboom A, Burgering BM. 2013. FOXOs: Signalling integrators for homeostasis maintenance. Nat Rev Mol Cell Biol. 14:83–97.
   PubMed Web of Science ®Google Scholar
• Furuyama T, Nakazawa T, Nakano I, Mori N. 2000. Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DA-16 homologues. Biochem J. 349:629–634.
   PubMed Web of Science ®Google Scholar
• Hegmans JP, Hemmes A, Hammad H, Boon L, Hoogsteden HC, Lambrecht BN. 2006. Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses. Eur Respir J. 27:1086–1095.
   PubMed Web of Science ®Google Scholar
• Huang SX, Jaurand MC, Kamp DW, Whysner J, Hei TK. 2011. Role of mutagenicity in asbestos fiber-induced carcinogenicity and other diseases. J Toxicol Environ Health. 14:179–245.
   Web of Science ®Google Scholar
• Hyodoh F, Takata-Tomokuni A, Miura Y, Sakaguchi H, Hatayama T, Hatada S, Katsuyama H, Matsuo Y, Otsuki T. 2005. Inhibitory effects of anti-oxidants on apoptosis of a human polyclonal T-cell line, MT-2, induced by an asbestos, chrysotile A. Scand J Immunol. 61:442–448.
   PubMed Web of Science ®Google Scholar
• Ireland DJ, Kissick HT, Beilharz MW. 2012. The role of regulatory T-cells in meso-thelioma. Cancer Microenviron. 5:165–172.
   PubMedGoogle Scholar
• Izzi V, Masuelli L, Tresoldi I, Foti C, Modesti A, Bei R. 2012. Immunity and malignant mesothelioma: from mesothelial cell damage to tumor development and immune response-based therapies. Cancer Lett. 322:18–34.
   PubMed Web of Science ®Google Scholar
• Jiang L, Akatsuka S, Nagai H, Chew SH, Ohara H, Okazaki Y, Yamashita Y, Yoshikawa Y, Yasui H, Ikuta K, et al. 2012. Iron overload signature in chrysotile-induced malignant mesothelioma. J Pathol. 228:366–377.
   PubMed Web of Science ®Google Scholar
• Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T, Kumagai H. 2003. Retrovirus-mediated gene transfer and expression cloning: Powerful tools in functional genomics. Exp Hematol. 31:1007–1014.
   PubMed Web of Science ®Google Scholar
• Kohyama N, Shinohara Y, Suzuki Y. 1996. Mineral phases and some re-examined characteristics of the International Union Against Cancer standard asbestos samples. Am J Indust Med. 30:515–528.
   PubMed Web of Science ®Google Scholar
• Kratzke RA, Otterson GA, Lincoln CE, Ewing S, Oie H, Geradts J, Kaye FJ. 1995. Immunohistochemical analysis of the p16INK4 cyclin-dependent kinase inhibitor in malignant mesothelioma. J Natl Cancer Inst. 87:1870–1875.
   PubMed Web of Science ®Google Scholar
• Kumagai-Takei N, Nishimura Y, Maeda M, Hayashi H, Matsuzaki H, Lee S, Hiratsuka J, Otsuki T. 2013. Effect of asbestos exposure on differentiation of cytotoxic T-lymphocytes in mixed lymphocyte reaction of human peripheral blood mononuclear cells. Am J Respir Cell Mol Biol. 49:28–36.
   PubMed Web of Science ®Google Scholar
• Lemen RA, Dodson R, Hammar S, editors. 2006. Epidemiology of asbestos-related diseases and the knowledge that led to what is known today. Boca Raton (FL): CRC Press.
   Google Scholar
• Maeda M, Miura Y, Nishimura Y, Murakami S, Hayashi H, Kumagai N, Hatayama T, Katoh M, Miyahara N, Yamamoto S, et al. 2008. Immunological changes in mesothelioma patients and their experimental detection. Clin Med Circ Respir Pulm Med. 2:11–17.
   PubMedGoogle Scholar
• Maeda M, Nishimura Y, Hayashi H, Kumagai N, Chen Y, Murakami S, Miura Y, Hiratsuka J, Kishimoto T, Otsuki T. 2011. Reduction of CXC chemokine receptor 3 in an in vitro model of continuous exposure to asbestos in a human T-cell line, MT-2. Am J Respir Cell Mol Biol. 45:470–479.
   PubMed Web of Science ®Google Scholar
• Maeda M, Nishimura Y, Kumagai N, Hayashi H, Hatayama T, Katoh M, Miyahara N, Yamamoto S, Hirastuka J, Otsuki T. 2010. Dysregulation of the immune system caused by silica and asbestos. J Immunotoxicol. 7:268–278.
   PubMed Web of Science ®Google Scholar
• Maeda M, Yamamoto S, Chen Y, Kumagai-Takei N, Hayashi H, Matsuzaki H, Lee S, Hatayama T, Miyahara N, Katoh M, et al. 2012. Resistance to asbestos-induced apoptosis with continuous exposure to crocidolite on a human T-cell. Sci Total Environ. 429:174–182.
   PubMed Web of Science ®Google Scholar
• Matsuzaki H, Maeda M, Lee S, Nishimura Y, Kumagai-Takei N, Hayashi H, Yamamoto S, Hatayama T, Kojima Y, Tabata R, et al. 2012. Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis. J Biomed Biotechnol. 2012:492608.
   PubMedGoogle Scholar
• Miura Y, Nishimura Y, Katsuyama H, Maeda M, Hayashi H, Dong M, Hyodoh F, Tomita M, Matsuo Y, Uesaka A, et al. 2006. Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T-cells. Apoptosis. 11:1825–1835.
   PubMed Web of Science ®Google Scholar
• Mizuno T, Murakami H, Fujii M, Ishiguro F, Tanaka I, Kondo Y, Akatsuka S, Toyokuni S, Yokoi K, Osada H, et al. 2012. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes. Oncogene. 31:5117–5122.
   PubMed Web of Science ®Google Scholar
• Murakami H, Mizuno T, Taniguchi T, Fujii M, Ishiguro F, Fukui T, Akatsuka S, Horio Y, Hida T, Kondo Y, et al. 2011. LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res. 71:873–883.
   PubMed Web of Science ®Google Scholar
• Nagata, S. 1997. Apoptosis by death factor. Cell. 88:355–365.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Sakaguchi S. 2010. Regulatory T-cells in tumor immunity. Intl J Cancer. 127:759–767.
   PubMed Web of Science ®Google Scholar
• Nishimura Y, Maeda M, Kumagai N, Hayashi H, Miura Y, Otsuki T. 2009a. Decrease in phosphorylation of ERK following decreased expression of NK cell-activating receptors in human NK cell line exposed to asbestos. Intl J Immunopathol Pharmacol. 22:879–888.
   PubMed Web of Science ®Google Scholar
• Nishimura Y, Miura Y, Maeda M, Kumagai N, Murakami S, Hayashi H, Fukuoka K, Nakano T, Otsuki T. 2009b. Impairment in cytotoxicity and expression of NK cell-activating receptors on human NK cells following exposure to asbestos fibers. Intl J Immunopathol Pharmacol. 22:579–590.
   PubMed Web of Science ®Google Scholar
• Ohkura N, Kitagawa Y, Sakaguchi S. 2013. Development and maintenance of regulatory T-cells. Immunity. 38:414–423.
   PubMed Web of Science ®Google Scholar
• Opitz I, Soltermann A, Abaecherli M, Hinterberger M, Probst-Hensch N, Stahel R, Moch H, Weder W. 2008. PTEN expression is a strong predictor of survival in mesothelioma patients. Eur J Cardiothorac Surg. 33:502–506.
   PubMed Web of Science ®Google Scholar
• Puthalakath H, Strasser A. 2002. Keeping killers on a tight leash: Transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 9:505–512.
   PubMed Web of Science ®Google Scholar
• Robinson BW, Musk AW, Lake RA. 2005. Malignant mesothelioma. Lancet. 366:397–408.
   PubMed Web of Science ®Google Scholar
• Roggli VL, Oury TD, Sporn TA, editors. 2004. Pathology of asbestos-associated diseases. New York: Springer Verlag.
   Google Scholar
• Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P. 2007. Role of chemokines in endocrine autoimmune diseases. Endocr Rev. 28:492–520.
   PubMed Web of Science ®Google Scholar
• Schreiber RD, Old LJ, Smyth MJ. 2011. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science. 331:1565–1570.
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Dobashi K, Imai H, Sunaga N, Ono A, Sano T, Hikino T, Shimizu K, Tanaka S, Ishizuka T, et al. 2009. CXCR4+FoxP3+CD25+ lymphocytes accumulate in CXCL12-expressing malignant pleural mesothelioma. Intl J Immunopathol Pharmacol. 22:43–51.
   PubMed Web of Science ®Google Scholar
• Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, et al. 2011. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet. 43:1022–1025.
   PubMed Web of Science ®Google Scholar
• Toyokuni S. 2009. Role of iron in carcinogenesis: Cancer as a ferrotoxic disease. Cancer Sci. 100:9–16.
   PubMed Web of Science ®Google Scholar
• Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S, Maeda M, Onodera M, Uchiyama T, Fujii S, et al. 2004. Crucial role of FoxP3 in the development and function of human CD25+CD4+ regulatory T-cells. Intl Immunol. 16:1643–1656.
   PubMed Web of Science ®Google Scholar